|
Dear Colleague:
The
increased number of abstracts and editorial comments published online
has been very well received by readers of GGH
journal. The feedback was praiseworthy, and there were a large number
of viewers who accessed the e-abstracts. Both of these aspects are
very rewarding to the Editorial Board. This issue also includes an
expanded format; there are 8 abstracts published in the print version
of the journal, plus one letter to the editor pertaining to the lead
article dealing with pregnancy in T1DM patients (published in Volume
20, Number 4 of GGH). In addition, there are 6 papers published in the e-version, (accessed
at www.GGHjournal.com). Altogether the Editorial Board canvassed and
reviewed some of the most pertinent papers in the current literature.
Finally, the lead article in this issue addresses a most important
topic, one that pediatric endocrinologists deal with on a daily
basis; namely, the evaluation of children with short stature. The
paper by Sandberg and Colsman is an erudite review of the facts and
pitfalls of the reports dealing with the psychosocial issues of short
stature. They discuss the science and evidence and/or the lack of it,
regarding the “heightism” prejudice that is so prevalent
in our society. It constitutes an important contribution for those in
practice dealing with short children, as well as for those interested
in psychosocial research.
In
May, 1985, I received an urgent call alerting me to the CJD
association with the growth hormone that was used to treat
hypopituitary patients. This hormone, extracted from cadaver
pituitary glands, was immediately pulled off the market and we were
left without any options to treat these patients. Fortunately,
recombinant human growth hormone was in the pipeline and was soon
available for clinical use. The 20th anniversary of this landmark
accomplishment by Genentech is worthy of recognition.
Fima Lifshitz, MD
|
Current GGH - Vol. 24 No. 1
print version (pdf)
Printer Friendly
Email Paper